ArticleDigestive diseases and sciences2012

KRAS mutation and NF-κB activation indicates tolerance of chemotherapy and poor prognosis in colorectal cancer.

Gen Lin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.